Excellent proliferation and persistence of allogeneic donor-derived 41-BB based CAR-T cells despite immunosuppression with cyclosporine A

被引:13
作者
Ayuk, Francis [1 ]
Fehse, Boris
Janson, Dietlinde
Berger, Carolina
Riecken, Kristoffer
Kroeger, Nicolaus
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
关键词
LEUKEMIA; TRANSPLANTATION; CHILDREN;
D O I
10.3324/haematol.2019.245969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E322 / E324
页数:3
相关论文
共 15 条
[1]   Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma [J].
Ayuk, F ;
Shimoni, A ;
Nagler, A ;
Schwerdtfeger, R ;
Kiehl, M ;
Sayer, HG ;
Zabelina, T ;
Zander, AR ;
Kröger, N .
LEUKEMIA, 2004, 18 (03) :659-662
[2]   Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease [J].
Brudno, Jennifer N. ;
Somerville, Robert P. T. ;
Shi, Victoria ;
Rose, Jeremy J. ;
Halverson, David C. ;
Fowler, Daniel H. ;
Gea-Banacloche, Juan C. ;
Pavletic, Steven Z. ;
Hickstein, Dennis D. ;
Lu, Tangying L. ;
Feldman, Steven A. ;
Iwamoto, Alexander T. ;
Kurlander, Roger ;
Maric, Irina ;
Goy, Andre ;
Hansen, Brenna G. ;
Wilder, Jennifer S. ;
Blacklock-Schuver, Bazetta ;
Hakim, Frances T. ;
Rosenberg, Steven A. ;
Gress, Ronald E. ;
Kochenderfer, James N. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1112-+
[3]   Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [J].
Collins, RH ;
Shpilberg, O ;
Drobyski, WR ;
Porter, DL ;
Giralt, S ;
Champlin, R ;
Goodman, SA ;
Wolff, SN ;
Hu, W ;
Verfaillie, C ;
List, A ;
Dalton, W ;
Ognoskie, N ;
Chetrit, A ;
Antin, JH ;
Nemunaitis, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :433-444
[4]   Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia [J].
Dai, Hanren ;
Zhang, Wenying ;
Li, Xiaolei ;
Han, Qingwang ;
Guo, Yelei ;
Zhang, Yajing ;
Wang, Yao ;
Wang, Chunmeng ;
Shi, Fengxia ;
Zhang, Yan ;
Chen, Meixia ;
Feng, Kaichao ;
Wang, Quanshun ;
Zhu, Hongli ;
Fu, Xiaobing ;
Li, Suxia ;
Han, Weidong .
ONCOIMMUNOLOGY, 2015, 4 (11)
[5]   Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults [J].
Gardner, Rebecca A. ;
Finney, Olivia ;
Annesley, Colleen ;
Brakke, Hannah ;
Summers, Corinne ;
Leger, Kasey ;
Bleakley, Marie ;
Brown, Christopher ;
Mgebroff, Stephanie ;
Kelly-Spratt, Karen S. ;
Hoglund, Virginia ;
Lindgren, Catherine ;
Oron, Assaf P. ;
Li, Daniel ;
Riddell, Stanley R. ;
Park, Julie R. ;
Jensen, Michael C. .
BLOOD, 2017, 129 (25) :3322-3331
[6]   Donor CD19 CART cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity [J].
Ghosh, Arnab ;
Smith, Melody ;
James, Scott E. ;
Davila, Marco L. ;
Velardi, Enrico ;
Argyropoulos, Kimon V. ;
Gunset, Gertrude ;
Perna, Fabiana ;
Kreines, Fabiana M. ;
Levy, Emily R. ;
Lieberman, Sophie ;
Jay, Hillary V. ;
Tuckett, Andrea Z. ;
Zakrzewski, Johannes L. ;
Tan, Lisa ;
Young, Lauren F. ;
Takvorian, Kate ;
Dudakov, Jarrod A. ;
Jenq, Robert R. ;
Hanash, Alan M. ;
Motta, Ana Carolina F. ;
Murphy, George F. ;
Liu, Chen ;
Schietinger, Andrea ;
Sadelain, Michel ;
van den Brink, Marcel R. M. .
NATURE MEDICINE, 2017, 23 (02) :242-249
[7]   Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells [J].
Kebriaei, Partow ;
Singh, Harjeet ;
Huls, M. Helen ;
Figliola, Matthew J. ;
Bassett, Roland ;
Olivares, Simon ;
Jena, Bipulendu ;
Dawson, Margaret J. ;
Kumaresan, Pappanaicken R. ;
Su, Shihuang ;
Maiti, Sourindra ;
Dai, Jianliang ;
Moriarity, Branden ;
Forget, Marie-Andree ;
Senyukov, Vladimir ;
Orozco, Aaron ;
Liu, Tingting ;
McCarty, Jessica ;
Jackson, Rinelca N. ;
Moyes, Judy S. ;
Rondon, Gabriela ;
Qazilbash, Muzaffar ;
Ciurea, Stefan ;
Alousi, Amin ;
Nieto, Yago ;
Rezvani, Katy ;
Marin, David ;
Popat, Uday ;
Hosing, Chitra ;
Shpall, Elizabeth J. ;
Kantarjian, Hagop ;
Keating, Michael ;
Wierda, William ;
Do, Kim Anh ;
Largaespada, David A. ;
Lee, Dean A. ;
Hackett, Perry B. ;
Champlin, Richard E. ;
Cooper, Laurence J. N. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (09) :3363-3376
[8]   GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS [J].
KOLB, HJ ;
SCHATTENBERG, A ;
GOLDMAN, JM ;
HERTENSTEIN, B ;
JACOBSEN, N ;
ARCESE, W ;
LJUNGMAN, P ;
FERRANT, A ;
VERDONCK, L ;
NIEDERWIESER, D ;
VANRHEE, F ;
MITTERMUELLER, J ;
DEWITTE, T ;
HOLLER, E ;
ANSARI, H .
BLOOD, 1995, 86 (05) :2041-2050
[9]   The effects of Cyclosporine A and azathioprine on human T cells activated by different costimulatory signals [J].
Leitner, Judith ;
Drobits, Karin ;
Pickl, Winfried F. ;
Majdic, Otto ;
Zlabinger, Gerhard ;
Steinberger, Peter .
IMMUNOLOGY LETTERS, 2011, 140 (1-2) :74-80
[10]   ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE [J].
MACKINNON, S ;
PAPADOPOULOS, EB ;
CARABASI, MH ;
REICH, L ;
COLLINS, NH ;
BOULAD, F ;
CASTROMALASPINA, H ;
CHILDS, BH ;
GILLIO, AP ;
KERNAN, NA ;
SMALL, TN ;
YOUNG, JW ;
OREILLY, RJ .
BLOOD, 1995, 86 (04) :1261-1268